Home
About
Overview
Sharing Data
ORCID
Help
History (67)
Vascular biomarkers in the prediction of clinical cardiovascular disease: the Strong Heart Study.
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial.
MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.
Use of the Physician Orders for Life-Sustaining Treatment among California Nursing Home Residents.
Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas.
See All 67 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas.
Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas. Blood Adv. 2020 09 08; 4(17):4256-4266.
View in:
PubMed
subject areas
B7-H1 Antigen
Humans
Immunotherapy
Lymphoma, T-Cell
T-Lymphocytes
Tumor Microenvironment
authors with profiles
Taha Al-Juhaishi